96V-0319 Laser light show
EXP 3 Eastern Kentucky University Vol#: 1
97P-0350 Reclassify Home Uterine Activity Monitors from III to II
AMD 1 HFZ-470 to GE Marquette Medical Systems, Vol#: 5
PAV 1 HFZ-470 to GE Marquette Medical Systems, Vol#: 5
98P-0151 Introduction Of Downed Cattle Into The Food Supply
C 3824 Malgosia Cegielski, Ph.D. Vol#: 120
C 3825 Lynn F. Wallace Vol#: 120
C 3826 Jan Cejka, Ph.D. Vol#: 120
C 3827 Lori A. Szewczyk Vol#: 120
C 3828 Barb & Joe McCarthy Vol#: 120
C 3829 Lisette C. Weishaupt Vol#: 120
C 3830 Margaret Q. Wehinger Vol#: 120
C 3832 Robin Gaye Thrapp Vol#: 120
C 3833 Margaret S. Wells Vol#: 120
C 3835 The H. T. Weston Family Vol#: 120
C 3837 Martha Carrington Vol#: 120
C 3838 Robert J. Langley Vol#: 120
C 3840 Pamela Buitrago Vol#: 120
C 3841 Khristi A. Tomlinson Vol#: 120
C 3842 Jacqueline Smith Wagoner Vol#: 120
C 3843 D L. F Vol#: 120
C 3844 Yvonne Ciccone Vol#: 120
C 3845 Maria Weizmann-Jaramillo Vol#: 120
C 3846 Ms. Kerul L. Kassel Vol#: 120
C 3847 Ms. Maryann Kirchenbauer Vol#: 120
C 3848 Rebecca Egbert Vol ol#: 120 #: 120
C 3849 Anne M. Stephany Vol#: 120
C 3850 Michelle Haag Vol#: 120
C 3851 Jo Ann Arcarise Vol#: 120
C 3852 Pamela L. Roudebush Vol#: 120
99N-1168 Public Health Impact of Foodborne Listeria Monocytogenes
EXT 1 LM Working Group Vol#: 1
99N-4282 Biotechnology in the Year 2000 and Beyond; Public Meetings
C 16938 Mitch Altman Vol#: 488
C 16939 Robert Lake Vol#: 488
C 16940 Lynda Means Vol#: 488
C 16941 Chris & Gail Ybarzabal Vol#: 488
C 16942 Ventine Hershey Vol#: 488
EMC 3373 Jacquelin Veros Vol#: 488
EMC 3374 Leah Haustman Vol#: 488
EMC 3375 Karen Snarr Vol#: 488
EMC 3376 Joshua Forgotson Vol#: 488
EMC 3377 David L Fritz Vol#: 488
EMC 3378 Kay Stoltz Vol#: 488
EMC 3379 Deborah Schwartz Vol#: 488
EMC 3380 Robin Pavolsky Vol#: 488
EMC 3381 Marlene Weir Vol#: 488
EMC 3382 Amy C Field Vol#: 488
EMC 3383 Leslie Martel Baer Vol#: 488
EMC 3384 Patrick Walz Vol#: 488
EMC 3385 Wanita Hauger Vol#: 488
99P-0485 Rescind Approval of Subtherapeutic Antibiotic Use Livestock
C 2829 James Stanford Vol#: 200
C 2830 Camina Tripodi Vol#: 200
C 2831 Constance C Schulz Vol#: 200
C 2832 Coriene Kelly Vol#: 200
C 2833 Miriam K Dailey Vol#: 200
C 2834 Selma Plotkin Vol#: 200
C 2835 Renee F Cooper Vol#: 200
C 2836 Rita J Bonasera Vol#: 200
C 2837 Elinore Tushner Vol#: 200
C 2840 Warren & Olive Wilson Vol#: 200
C 2841 Lourdes T Sadanaga Vol#: 200
C 2843 Gerald G Geci Vol#: 200
C 2844 Marcine D Bendtsen Vol#: 200
C 2845 Jane Desotelle Vol#: 200
C 2851 Phillip H Coe Vol#: 200
C 2853 Jessie Gretzinger Vol#: 200
C 2854 Pat Christensen Vol#: 200
C 2855 Virginia Fabilli Vol#: 200
C 2856 Marjorie Williams Vol#: 200
C 2857 Everett Peterson Vol#: 200
C 2860 Richard W Lyman Vol#: 200
C 2862 Janet H Penderass Vol#: 200
C 2863 Charles Safiran Vol#: 200
C 2865 Judith A Johnsen Vol#: 200
C 2867 M Virginia Grady Vol#: 200
EMC 390 L Privitera Vol#: 200
EMC 391 P Prober Vol#: 200
EMC 392 J Servais Vol#: 200
EMC 393 P Cantrell Vol#: 200
EMC 394 G Shotz Vol#: 200
EMC 395 T Ellison Vol#: 200
99V-1272 Laser Light Show-Omniscan Laser Projection System Model 2000
EXP 1 AVI, Imagineering With Lasers Vol#: 1
00D-1492 Mutual Recognition Agreement,Medical Device Annex Confidence
LET 1 Merck Frosst Canada & Co. Vol#: 1
00D-1562 Clinical Data In Marketing Applications
00D-1563 Industry on Carcinogenicity Study protocol submissions
C 2 Triangle Pharmaceuticals Vol#: 1
C 3 AstraZeneca Pharmaceuticals LP Vol#: 1
C 4 Alza Corp. Vol#: 1
C 5 Merck & Co, Inc. Vol#: 1
C 6 Pharmacia Corp. Vol#: 1
C 7 DuPont Pharmaceuticals Co. Vol#: 1
00D-1587 Medical Devices Guidance for Prescription Drugs Abuse Assays
C 1 Medtox Diagnostic Inc Vol#: 1
00D-1598 Voluntary Labeling for Bioengineered Foods
EC 90 Mr. Bruce Hearle Vol#: 23
EC 91 Ms. Kimberly Smith Vol#: 23
EC 92 Ms. Joane Kulish Vol#: 23
EC 93 Ms. Rebecca Thibault Vol#: 23
EC 94 Ms. Martha Forrester Vol#: 23
EC 95 Mr. Dave Turner Vol#: 23
EC 96 Ms. Tracy Miller Vol#: 23
EC 97 Ms. Lynne Simpson Vol#: 23
EC 99 Mrs. Elise Miller Vol#: 23
EC 100 Ms. Gina Miller Vol#: 23
EC 101 Mr. W. Dean Mindock Vol#: 23
EC 102 Mrs. Cheri Smith Vol#: 23
EC 104 Ms. MARTHA Bennett Vol#: 23
EC 105 Ms. Gerianne Carillo Vol#: 23
EC 106 organically grown company Vol#: 23
EC 107 Mrs. Holly Mawby Vol#: 23
EC 108 Mrs. Linda Clevinger Vol#: 23
EC 109 Mr. Craig Weber Vol#: 23
EC 110 Mrs. Lois Hluhan Vol#: 23
EC 111 Ms. Loie Atkinson Vol#: 23
EC 112 Mr. Edund Fladung Vol#: 23
EC 113 Wood Creek Farm Vol#: 23
EC 114 Ms. Micky Komara Vol#: 23
EC 115 Ms. Cindi Cochran Vol#: 23
EC 116 Ms. Anna Dominguez Vol#: 23
EC 117 Mr. Rick Adams Vol#: 23
EC 118 Ms. Donna Quinn Vol#: 23
EC 119 Mr. Mike Torreyson Vol#: 23
EC 121 Ms. Cynthia Coachman Vol#: 23
EC 122 Copper River School District Vol#: 23
00D-1632 Management of Adverse Event Reports (AER's) (VICH GL24)
C 2 Animal Health Inst (AHI) Vol#: 1
00N-1269 Labeling for human prescription drug/Biologic Products
C 4 Arrowsmith-Lowe Consulting Inc Vol#: 2
EXT 1 Pharmaceutical Research & Manufac(PhRMA) Vol#: 2
00N-1357 FDA Concept Paper:Demonstrably Difficult to Compound Drugs
C 25 Luitpold Pharmaceuticals, Inc. Vol#: 2
00N-1396 Bioengineered Foods Consumed By Humans or Animals
EMC 36 Form Letter Count Vol#: 14
EMC 57 Number Not Used Vol#: 15
EMC 63 W F Wolfe, Jr. Vol#: 15
EMC 65 J A Swaney, Ph.D. Vol#: 15
EMC 69 M Schwartz, M.D. Vol#: 15
EMC 82 P Snouffer, RN, BSN Vol#: 15
EMC 90 B Harper-McIntosh Vol#: 15
00N-1521 Agency Information Collection Act: Food Labeling Regulations
00N-1545 Proposed Revision of Postmarketing Reporting Requirements
C 2 Aventis Pharmaceuticals Vol#: 1
C 3 AstraZeneca Pharmaceuticals LP Vol#: 1
00N-1666 Abbreviated New Drug Application Regulations; Patent & Exclu
EC 3 Mr. Larry Shepherd Vol#: 1
00N-1669 Electronic filing of drug registration and listing informati
LET 30 Amide Pharmaceutical Inc Vol#: 1
LET 31 Procter & Gamble Co Vol#: 1
LET 32 McNeil Consumer Healthcare Vol#: 1
LET 33 Pharmaceutical Research Inst Vol#: 1
LET 34 Solvay Pharcaceuticals Inc Vol#: 1
LET 35 Gensia Sicor Pharcaceuticals Inc Vol#: 1
LET 36 Baxter Healthcare Corp Vol#: 1
00N-1686 Electronic INDA cumulative table of contents public meeting
00P-1352 ANDA Suitability Petition Camiodarone Hydrochloride Injectio
PAV 1 HFD-600 TO GensiaSicor Pharmaceuticals Vol#: 1
00P-1365 ANDA be submitted for Fluoxetine Tablets/40 mg
PAV 1 HFD-600 to Lachman Consultants Services Vol#: 1
00P-1419 ANDA for Gabapentin Tablets 100 mg 300 mg and 400 mg
PAV 1 HFD-600 to Lachman Consultant Services Vol#: 1
00P-1470 ANDA 75-880 for 6%and10% PremaSol-sulfite-free (Amino Acid)
PAV 1 HFD-600 to Baxter Healthcare Corporation Vol#: 1
00P-1551 Determine an ANDA may be submitted for a propxphene Napsylat
PAV 1 HFD-600 to Arnall Golden & Gregory, LLP Vol#: 1
00P-1564 Grant a temporary exemption for one packaging component
WDL 1 Alcon Research LTD. Vol#: 1
00P-1577 Variance from source-skin distance requirement of perf. std.
PAV 1 HFZ-340 to GE OEC Medical Systems, Inc. Vol#: 1
00P-1600 ANADA Suitability for Ivermectin
LET 1 Royer Biomedical, Inc. Vol#: 1
LET 2 Royer Biomedical, Inc. Vol#: 1
01M-0072 PMA Pro-Trac II Tacrolimus ELISA Kit, P970025
AAV 1 Diasorin Inc Vol#: 1
01P-0075 Switch Status of Emergency Contraceptives from Rx to OTC